Fda Authorizes Novavax Covid-19 Vaccine For Emergency Use In Ages 12-17

CNN.com - RSS Channel - Health, CNN: Health
Fri, 08/19/2022 - 11:20pm

The US Food and Drug Administration authorized Novavax's Covid-19 vaccine on Friday for emergency use in adolescents. It is the fourth coronavirus vaccine available in the United States and, unlike the others, is uses a protein-based technology.

NEXT
Topics:  health   
RELATED ARTICLES
  • no title provided in feed
    CNN's Dr. Sanjay Gupta speaks to registered nurse Kate Carleton about her efforts to prepare schoolchildren to treat injuries suffered in a mass shooting. More
  • no title provided in feed
    These senior citizens have waited on the phone for hours, driven miles, set-up work stations so they could get a Covid-19 vaccine appointment. See who was able to get one. More
  • no title provided in feed
    The global fertility rate has fallen from 5 births per woman in 1950 to 2.3 in 2021 - and even lower in the U.S., partly due to the cost of child-rearing and shifts in priorities. But "falling population and an elderly or aging population puts a lot of fiscal and economic pressures on society," says Economics Professor Melissa Kearney. More
  • no title provided in feed
    Independent presidential candidate Robert F. Kennedy Jr. told The New York Times he experienced a series of health issues in recent years, including an abnormality that he said was caused by a worm that entered his brain and then died. More
  • no title provided in feed
    Americans' mental health issues are not identified and treated as readily as physical symptoms, especially among children - in part due to a shortage of clinicians. "We're looking for ways to integrate mental health into settings where children and families are every day," says Dr. More
  • no title provided in feed
    Mayor Donna Deegan speaks with CNN's Jake Tapper More
BING NEWS:
  • Novavax says Australia cancels delivery of some Covid-19 doses
    In a regulatory filing, Novavax (NVAX) disclosed that, on December 12, the company entered into Amendment #5 to the Advanced Purchase ...
    12/18/2024 - 9:35 am | View Link
  • FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates
    The FDA has granted fast track designation to two combination vaccine candidates that aim to protect adults 50 and older from both influenza and COVID-19, according to a Dec. 16 AJMC report. These ...
    12/17/2024 - 3:08 am | View Link
  • Two Combination Vaccines Fast Tracked for Influenza and COVID-19
    The FDA has granted Fast Track designation to 2 investigational combination vaccines to prevent influenza and COVID-19 infections in adults 50 years and older.
    12/16/2024 - 1:08 am | View Link
  • Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation
    is comprised of the influenza protein-based trivalent vaccine Fluzone High-Dose combined with the adjuvanted recombinant Novavax COVID-19 vaccine. The second candidate (NCT06695130) includes the ...
    12/15/2024 - 11:00 am | View Link
  • NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
    Novavax NVAX announced that it has started dosing participants in the phase III study evaluating its experimental COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates. The ...
    12/10/2024 - 11:50 pm | View Link
  • More

 

NEXT